DK595187A - Minactivin og fremgangsmaade til fremstilling deraf - Google Patents

Minactivin og fremgangsmaade til fremstilling deraf

Info

Publication number
DK595187A
DK595187A DK595187A DK595187A DK595187A DK 595187 A DK595187 A DK 595187A DK 595187 A DK595187 A DK 595187A DK 595187 A DK595187 A DK 595187A DK 595187 A DK595187 A DK 595187A
Authority
DK
Denmark
Prior art keywords
minactivin
purification
biologically active
relates
producing
Prior art date
Application number
DK595187A
Other languages
English (en)
Other versions
DK595187D0 (da
DK172400B1 (da
Inventor
Toni Marie Antalis
Michael Thomas Barnes
Michelle Alison Clarke
Peter Leonard Devine
Neil Howard Goss
Philip Ralph Lehrbach
Original Assignee
Biotech Australia Pty Ltd
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Australian filed Critical Biotech Australia Pty Ltd
Publication of DK595187D0 publication Critical patent/DK595187D0/da
Publication of DK595187A publication Critical patent/DK595187A/da
Application granted granted Critical
Publication of DK172400B1 publication Critical patent/DK172400B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8132Plasminogen activator inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972Plasminogen activators
    • G01N2333/9723Urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
DK595187A 1986-03-13 1987-11-13 Fremgangsmåde til fremstilling af renset minactivin, minactivinkodende DNA-molekyle, rekombinant DNA-molekyle, sammensmeltet gen, vært, reagent til lokalisering og definering af grænserne for tumorer i histologiske prøver, samt anvendelse af det rekombinante DNA-molekyle, minactivinet og peptider deraf DK172400B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
AUPH501786 1986-03-13
AUPH501786 1986-03-13
AUPH603386 1986-05-22
AUPH603386 1986-05-22
AUPH810086 1986-09-18
AUPH810086 1986-09-18
AUPH910486 1986-11-21
AUPH910486 1986-11-21
AU8700068 1987-03-13
PCT/AU1987/000068 WO1987005628A1 (en) 1986-03-13 1987-03-13 Minactivin produced by recombinant dna technology

Publications (3)

Publication Number Publication Date
DK595187D0 DK595187D0 (da) 1987-11-13
DK595187A true DK595187A (da) 1988-07-21
DK172400B1 DK172400B1 (da) 1998-05-18

Family

ID=27424177

Family Applications (2)

Application Number Title Priority Date Filing Date
DK595187A DK172400B1 (da) 1986-03-13 1987-11-13 Fremgangsmåde til fremstilling af renset minactivin, minactivinkodende DNA-molekyle, rekombinant DNA-molekyle, sammensmeltet gen, vært, reagent til lokalisering og definering af grænserne for tumorer i histologiske prøver, samt anvendelse af det rekombinante DNA-molekyle, minactivinet og peptider deraf
DK027097A DK27097A (da) 1986-03-13 1997-03-13 Minactivin og fremgangsmåde til fremstilling deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK027097A DK27097A (da) 1986-03-13 1997-03-13 Minactivin og fremgangsmåde til fremstilling deraf

Country Status (13)

Country Link
US (1) US5426044A (da)
EP (1) EP0238275B1 (da)
JP (2) JP2589996B2 (da)
KR (1) KR960001820B1 (da)
CN (2) CN1032019C (da)
AT (1) ATE132192T1 (da)
CA (1) CA1338381C (da)
DE (1) DE3751646T2 (da)
DK (2) DK172400B1 (da)
IL (1) IL81879A (da)
NO (1) NO178504C (da)
NZ (1) NZ219608A (da)
WO (1) WO1987005628A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
DK0446315T3 (da) * 1989-09-05 1998-01-05 Biotech Australia Pty Ltd Fremgangsmåde til fremstilling af PAI-2
AU625018B2 (en) * 1989-12-20 1992-06-25 Biotech Australia Pty Limited Variants of pai-2
GB9026737D0 (en) * 1990-12-08 1991-01-30 Delta Biotechnology Ltd Cancer treatment
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
CN102586187A (zh) * 2012-02-23 2012-07-18 深圳市中美康士生物科技有限公司 一种中性粒细胞体外保存方法及培养基

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
JPH0655152B2 (ja) * 1984-08-13 1994-07-27 バイオテクノロジー・オーストラリア・ピーテイーワイ・リミテツド ミナクチビンの製造方法
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation

Also Published As

Publication number Publication date
EP0238275B1 (en) 1995-12-27
ATE132192T1 (de) 1996-01-15
CA1338381C (en) 1996-06-11
KR960001820B1 (ko) 1996-02-05
DE3751646T2 (de) 1996-10-17
DK595187D0 (da) 1987-11-13
WO1987005628A1 (en) 1987-09-24
JP2660681B2 (ja) 1997-10-08
DK27097A (da) 1997-03-13
CN87102725A (zh) 1987-11-11
NO178504B (no) 1996-01-02
US5426044A (en) 1995-06-20
EP0238275A3 (en) 1989-05-10
JPH08112094A (ja) 1996-05-07
DE3751646D1 (de) 1996-02-08
NO874704D0 (no) 1987-11-11
CN1100957A (zh) 1995-04-05
NZ219608A (en) 1991-05-28
IL81879A (en) 1994-07-31
NO178504C (no) 1996-04-10
CN1032019C (zh) 1996-06-12
EP0238275A2 (en) 1987-09-23
JPS63503354A (ja) 1988-12-08
NO874704L (no) 1987-11-11
JP2589996B2 (ja) 1997-03-12
KR880701073A (ko) 1988-07-25
DK172400B1 (da) 1998-05-18

Similar Documents

Publication Publication Date Title
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
DK17986A (da) Oligopeptider samt mellemprodukter og fremgangsmaade til fremstilling deraf
RU95115239A (ru) Аналог эритропоэтина
FI100056B (fi) Ihmisproapolipoproteiinin A-I ilmaiseminen
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
NO180239C (no) Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid
DE69534600D1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
DE69434839D1 (de) Transferrin-rezeptor gene von haemophilus
DE69117123D1 (de) Menschliches MK Gen und Protein-Sequenz
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
NO930428L (no) Proteinstrukturen til plantetoksingelonin
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
DE59108947D1 (de) Neues menschliches, rekombinantes interferon gamma
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
ATE171217T1 (de) Methoden zur synthese und reinigung von peptiden
DE69633179D1 (de) Transferrinrezeptorgene
DE69330348D1 (de) Verwendung von Peptiden welche eine Immunantwort bewirken zur Herstellung von Medikamenten zur Induzierung der Immunsuppression.
DE3686466D1 (de) Polypeptide, deren kodierende peptide und methode zur herstellung dieser peptide und dnas.
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.

Legal Events

Date Code Title Description
ATS Application withdrawn
AHS Application shelved for other reasons than non-payment
AHS Application shelved for other reasons than non-payment
AHS Application shelved for other reasons than non-payment
AHS Application shelved for other reasons than non-payment
AHS Application shelved for other reasons than non-payment
AHB Application shelved due to non-payment
AGE Re-establishment of rights: approved
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK